TABLE 2

Demographic and Clinical Characteristics, Laboratory Values, and Clinical Outcomes of KD Patients With and Without a Positive RVP

Variable Positive RVP (n = 93)Negative RVP (n = 99)P
Demographic characteristics
 Age, y2.92 (1.48–4.55)3.52 (1.78–6.28).07
 Male sex54 (58.1)57 (57.6).95
Clinical characteristics
 Day of illness at admission6 (5–8)6 (5–8).86
 History of URTI17 (18.3)14 (14.1).44
 Current URTI symptoms46 (49.5)42 (42.4).33
 History of GI illness14 (15.1)18 (18.1).56
 Current GI symptoms43 (46.2)49 (50).60
 Complete presentation64 (68.8)74 (74.8).36
 Day of illness at IVIG administration7 (5–9)7 (6–8).85
Laboratory values
 WBC count, 103/μL12.5 (10.2–14.8)12.9 (9.1–15.6).94
 PMNs, %66.1 (52–74.3)65.5 (52.9–75.1).77
 Bands, %0 (0–9)0 (0–11).90
 Lymphocytes, %17 (8–27.6)15 (8.2–27.1).48
 Hematocrit, %33.8 (31.3–36.6)34.7 (32.4–36.7).28
 Platelet count, 103/μL332.5 (267–422)356 (303–453).29
 Highest CRP, mg/dL6.6 (3.3–11.2)7.2 (4.4–12.7).33
 Highest ESR, mm/h62.5 (43–82)60 (45–83).72
 Albumin, g/dL3.5 (3.1–3.8)3.6 (3.2–3.9).44
 AST, U/L49 (32–63.5)41.5 (28.5–67).19
 ALT, U/L34 (18–98)44.5 (20–81).39
 Alkaline phosphatase, U/L181 (137–275)209.5 (158.5–268).14
 Bilirubin, mg/dL0.4 (0.3–0.7)0.5 (0.3–0.9).37
 GGT, U/L35 (15–135)57 (19–136).15
Clinical outcomes
 PICU admission10 (10.9)6 (6.1).23
 IVIG resistant19 (20.7)18 (18.4).69
 Coronary artery lesions16 (17.2)18 (18.1)1.00
 Persistent coronary artery lesionsa3 (3.2)7 (7.1).33
  • Data are presented as n (%) or median (interquartile range). ALT, alanine aminotransferase; AST, aspartate aminotransferase; CRP, C-reactive protein; ESR, erythrocyte sedimentation rate; GGT, γ-glutamyl transferase; GI, gastrointestinal; PMN, polymorphonuclear cells; RVP, respiratory viral panel; WBC, white blood cell count.

  • a Coronary artery lesions persisting for >2 months.